Automate Your Wheel Strategy on MED
With Tiblio's Option Bot, you can configure your own wheel strategy including MED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MED
- Rev/Share 49.6394
- Book/Share 19.2692
- PB 0.6809
- Debt/Equity 0.0693
- CurrentRatio 3.5236
- ROIC -0.027
- MktCap 144201920.0
- FreeCF/Share 1.2299
- PFCF 10.7094
- PE -20.5285
- Debt/Assets 0.0522
- DivYield 0
- ROE -0.0336
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Medifast (MED) Up 10.9% Since Last Earnings Report: Can It Continue?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Read More
Medifast Trades Near 52-Week Low: What's the Best Move Now?
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Positive
MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives.
Read More
Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
Published: March 28, 2025 by: Seeking Alpha
Sentiment: Negative
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as a GLP-1 adjacent business, but the repositioning hasn't shown results so far with a deteriorating immediate earnings outlook. MED stock now trades below the company's net cash position, but due to high earnings uncertainty, the low valuation is justified.
Read More
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Medifast, Inc. (NYSE:MED ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson Operator Greetings and welcome to the Medifast Fourth Quarter 2024 Earnings Conference Call.
Read More
Medifast (MED) Q4 Earnings and Revenues Beat Estimates
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Medifast (MED) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to earnings of $1.09 per share a year ago.
Read More
About Medifast, Inc. (MED)
- IPO Date 1993-12-30
- Website https://medifastinc.com
- Industry Personal Products & Services
- CEO Daniel R. Chard
- Employees 504